We’re never going to nave a one-size-fits-all immunotherapy treatment for lung cancer patients – Thomas Marron
Cancer Research Institute (CRI) shared on LinkedIn:
“The reality is that lung cancer isn’t just one illness. Everybody has a completely different disease, and they have a completely different immune system that has seen different viruses and bacteria throughout their life.
Because of that, we’re never going to have a one-size-fits-all immunotherapy treatment for patients, ‘explains CRI Clinical Innovator Dr. Thomas Marron of Icahn School of Medicine at Mount Sinai, ‘but we are slowly moving to a world in which we will have a more personalized approach…where we’ll be identifying up-front which patients will respond best to which therapies.’
Learn more about the latest developments in cancer immunotherapy research for lung cancer during the Cancer Research Institute’s virtual Patient Immunotherapy Summit.”
Proceed to the video attached to the post.
Source: CRI/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023